Instead, use of DNMTs inhibitors, such as 5-Aza, seems to reverse the methylation in IDH-mutant tumors, suppressing tumor growth and inducing differentiation in IDH mutant glioma cells, but their effect on tumor metabolism is not yet known [162,163]. The gene discussed is IDH2; the disease is central nervous system cancer.